Contrast Material
Contrast in Imaging
Definition: Contrast media enhance the visibility of structures in imaging techniques.
Types of Imaging Techniques Affected:
X-ray: Contrast affects tissue X-ray attenuation.
Ultrasound: Contrast affects tissue and blood reflectivity.
MRI: Contrast affects tissue relaxation times.
Main Focus: Discussion primarily on contrast media for angiography and vascular diagnosis.
Intravascular X-ray Contrast Agents
Categories: X-ray contrast agents are categorized based on their effect on X-ray attenuation.
Positive Contrast Agents:
Have greater attenuation than soft tissues due to presence of iodine or gadolinium.
Negative Contrast Agents:
Currently, carbon dioxide gas is the only option with lower attenuation than tissues.
Usage:
Non-ionic contrast media are recommended for high-risk patients, replacing ionic agents.
Optimal contrast volume and placement are essential for clear images.
300 mg/mL iodine contrast is commonly used for large vessels, diluted for smaller injections.
Contrast Administration Principles
Goals:
To ensure the contrast column opacifies the vessel segment.
Adjust total contrast dose and bolus duration according to blood flow speed.
Increasing contrast volume helps visualize distal vessels.
Multiple imaging integration may improve visualization but can degrade quality.
Contrast Reactions with Iodinated Media
Classification of Reactions
Direct Effects: Related to osmolality and chemotoxicity. Symptoms include:
Heat
Nausea
Pain
Renal effects are critical, especially in patients with pre-existing conditions.
Idiosyncratic Reactions: Mechanism often unclear, severity ranges from minor to severe:
Minor: Common, e.g., metallic taste, mild nausea.
Intermediate: e.g., urticaria, responds to treatment.
Severe: Rare, e.g., circulatory collapse, requires prompt intervention.
Assessing and Reducing Risk of Contrast Reactions
High-Risk Factors:
Previous allergies to iodine or shellfish, cardiac disease, asthma, use of certain drugs, and age >50.
Risk Mitigation Strategies:
Constant supervision post-injection (20 minutes).
Non-ionic contrast agents to reduce risks.
Patient reassurance.
Steroid pre-medication may help but should be given 24 hours before the procedure.
Treatment for Contrast Reactions
Minor:
Nausea, vomiting often do not require treatment.
For urticaria: monitor; localized may not need treatment while generalized should.
Intermediate to Severe:
Bronchospasm: administer oxygen, beta-agonist, and possibly adrenaline.
Laryngeal oedema: monitor oxygen levels; may require tracheostomy.
Severe hypotension: immediate IV fluid resuscitation.
MRI Contrast Agents
Gadolinium: Effective for MRI but poses risks of nephrotoxicity, especially in high doses.
Nephrogenic Systemic Fibrosis (NSF): Risk factors include:
GFR <30 mL/min/1.7 m², particularly concerning for patients on dialysis.
Reference local guidelines for gadolinium agent use.
Negative Contrast Agents: Currently, CO₂ is the primary agent available.